{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild\nType Glioma with an FGFR-TACC Gene Fusion","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-2-study-of-erdafitinib-in-patients-with-recurrent-or-progressive-idh-wildtype-glioma-with-an-fgfr-tacc-gene-fusion\/#breadcrumbitem"}]}